» Articles » PMID: 30102693

Understanding Preferences for HIV Care and Treatment in Zambia: Evidence from a Discrete Choice Experiment Among Patients Who Have Been Lost to Follow-up

Abstract

Background: In public health HIV treatment programs in Africa, long-term retention remains a challenge. A number of improvement strategies exist (e.g., bring services closer to home, reduce visit frequency, expand hours of clinic operation, improve provider attitude), but implementers lack data about which to prioritize when resource constraints preclude implementing all. We used a discrete choice experiment (DCE) to quantify preferences for a number of potential clinic improvements to enhance retention.

Methods And Findings: We sought a random sample of HIV patients who were lost to follow-up (defined as >90 days late for their last scheduled appointment) from treatment facilities in Lusaka Province, Zambia. Among those contacted, we asked patients to choose between 2 hypothetical clinics in which the following 5 attributes of those facilities were varied: waiting time at the clinic (1, 3, or 5 hours), distance from residence to clinic (5, 10, or 20 km), ART supply given at each refill (1, 3, or 5 months), hours of operation (morning only, morning and afternoon, or morning and Saturday), and staff attitude ("rude" or "nice"). We used mixed-effects logistic regression to estimate relative utility (i.e., preference) for each attribute level. We calculated how much additional waiting time or travel distance patients were willing to accept in order to obtain other desired features of care. Between December 9, 2015 and May 31, 2016, we offered the survey to 385 patients, and 280 participated (average age 35; 60% female). Patients exhibited a strong preference for nice as opposed to rude providers (relative utility of 2.66; 95% CI 1.9-3.42; p < 0.001). In a standard willingness to wait or willingness to travel analysis, patients were willing to wait 19 hours more or travel 45 km farther to see nice rather than rude providers. An alternative analysis, in which trade-offs were constrained to values actually posed to patients in the experiment, suggested that patients were willing to accept a facility located 10 km from home (as opposed to 5) that required 5 hours of waiting per visit (as opposed to 1 hour) and that dispensed 3 months of medications (instead of 5) in order to access nice (as opposed to rude) providers. This study was limited by the fact that attributes included in the experiment may not have captured additional important determinants of preference.

Conclusions: In this study, patients were willing to expend considerable time and effort as well as accept substantial inconvenience in order to access providers with a nice attitude. In addition to service delivery redesign (e.g., differentiated service delivery models), current improvement strategies should also prioritize improving provider attitude and promoting patient centeredness-an area of limited policy attention to date.

Citing Articles

Preference for HIV testing among community residents in Yunnan Province, China: results from a discrete choice experiment.

Yang J, Qiu C, Tang R, Dong W, Yao E, Wang H BMC Health Serv Res. 2025; 25(1):216.

PMID: 39920697 PMC: 11803934. DOI: 10.1186/s12913-025-12357-w.


Experiences and Preferences in Zambia and South Africa for Delivery of HIV Treatment During a Client's First Six Months: Results of the PREFER Study's Cross-Sectional Baseline Survey.

Mutanda N, Morgan A, Kamanga A, Sande L, Ntjikelane V, Maskew M AIDS Behav. 2025; .

PMID: 39891834 DOI: 10.1007/s10461-025-04640-y.


The impact of COVID-19 on HIV care: a comprehensive analysis of patient and healthcare providers experiences at the largest HIV treatment center in Ghana.

Puplampu P, Baah J, Afoduo K, Adjei B, Abaidoo-Myles A, Davila-Roman V BMC Health Serv Res. 2025; 25(1):28.

PMID: 39762820 PMC: 11705771. DOI: 10.1186/s12913-024-12193-4.


Leadership, cohesion, and stress in primary care facilities and retention in chronic care in rural northeast South Africa before and during the COVID-19 pandemic: A longitudinal study.

Leslie H, Sibanda M, Kahn K, Tollman S, Masilela N, Gomez-Olive F J Glob Health. 2024; 14:05035.

PMID: 39652086 PMC: 11627195. DOI: 10.7189/jogh.14.05035.


The heterogeneity among people re-engaging in antiretroviral therapy highlights the need for a differentiated approach: results from a cross-sectional study in Johannesburg, South Africa.

Mutyambizi C, Rees K, Grimsrud A, Ndou R, Wilkinson L J Int AIDS Soc. 2024; 27(12):e26395.

PMID: 39648158 PMC: 11625505. DOI: 10.1002/jia2.26395.


References
1.
Terris-Prestholt F, Hanson K, MacPhail C, Vickerman P, Rees H, Watts C . How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa. PLoS One. 2014; 8(12):e83193. PMC: 3875434. DOI: 10.1371/journal.pone.0083193. View

2.
Topp S, Mwamba C, Sharma A, Mukamba N, Beres L, Geng E . Rethinking retention: Mapping interactions between multiple factors that influence long-term engagement in HIV care. PLoS One. 2018; 13(3):e0193641. PMC: 5851576. DOI: 10.1371/journal.pone.0193641. View

3.
Amanyire G, Wanyenze R, Alamo S, Kwarisiima D, Sunday P, Sebikaari G . Client and provider perspectives of the efficiency and quality of care in the context of rapid scale-up of antiretroviral therapy. AIDS Patient Care STDS. 2010; 24(11):719-27. PMC: 2994592. DOI: 10.1089/apc.2010.0108. View

4.
Mangham L, Hanson K, McPake B . How to do (or not to do) ... Designing a discrete choice experiment for application in a low-income country. Health Policy Plan. 2008; 24(2):151-8. DOI: 10.1093/heapol/czn047. View

5.
Kruk M, Riley P, Palma A, Adhikari S, Ahoua L, Arnaldo C . How Can the Health System Retain Women in HIV Treatment for a Lifetime? A Discrete Choice Experiment in Ethiopia and Mozambique. PLoS One. 2016; 11(8):e0160764. PMC: 4994936. DOI: 10.1371/journal.pone.0160764. View